| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LIDER
|
28.16 | 22.9B | 2.84 | 1.52 | 2.45 | -0.2% | 39.6% | 69 | 29 | 68.62 | +99.1% | 77 | 0.17 |
|
BEYAZ
|
21.88 | 2.2B | — | 1.67 | 8.06 | 22.1% | 40.4% | 53 | 52 | 25.80 | +13.3% | 71 | 0.26 |
|
BORLS
|
3.88 | 2.7B | — | — | 5.58 | -2.6% | 30.6% | 36 | 31 | 5.91 | +22.4% | 16 | -10.58 |
|
ESCAR
|
44.54 | 22.3B | — | 3.21 | 20.64 | -9.9% | 39.4% | 33 | 16 | 21.09 | -26.8% | 50 | 0.43 |
|
HRKET
|
91.40 | 10.5B | — | 1.39 | 42.39 | 1.8% | 31.8% | 31 | 24 | 65.56 | -14.4% | 32 | 0.52 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.